Difference between revisions of "Part:BBa K5184033"
(→‎Part Collection)
 
(3 intermediate revisions by 2 users not shown)
Line 16: Line 16:
 
<center><b>Fig1: (A) Cysteine cross-bridge structure in HxTx-Hv1h (B) Secondary structure of HxTx-Hv1h, by structural prediction results from AlphaFold. The cysteine residues are colored orange, displaying their side chains and the rest of the peptide in white</b></center>
 
<center><b>Fig1: (A) Cysteine cross-bridge structure in HxTx-Hv1h (B) Secondary structure of HxTx-Hv1h, by structural prediction results from AlphaFold. The cysteine residues are colored orange, displaying their side chains and the rest of the peptide in white</b></center>
  
−
Paralysis and mortal effects of susceptible subjects are achieved via HxTx-Hv1h inhibition on both CaV and KV channels of susceptible targets by blocking the channels directly, resulting in impediment of fundamental nervous system responses in neuronal, muscular, and cardiac functions. (Specific site of inhibition depends on the concentration of neurotoxin).
+
Paralysis and mortal effects of susceptible subjects are achieved via HxTx-Hv1h inhibition on both CaV and KCa channels of susceptible targets by blocking the channels directly, resulting in impediment of fundamental nervous system responses in neuronal, muscular, and cardiac functions. (Specific site of inhibition depends on the concentration of neurotoxin).
  
 
===Toxicity Verification===
 
===Toxicity Verification===
−
HxTx-Hv1h is synthesized using the vector pTE28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His[Fig2B], of which is assembled using GoldenGate cloning and transformed into <i>E. coli</i> strain DH5ɑ. Colony PCR and sequencing is then carried out to verify the plasmid construct, of which is extracted and transformed into BL21(DE3) strain for expression. After IPTG induction and overnight incubation, the liquid culture is harvested and, after cell lysis, have an SDS-PAGE run. The results suggest that HxTx-Hv1h had achieved soluble expression. After several unsuccessful purification attempts, the supernatant is treated directly by SUMO protease [Fig2C].
+
HxTx-Hv1h is synthesized using the vector pET28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His[Fig2B], of which is assembled using GoldenGate cloning and transformed into <i>E. coli</i> strain DH5ɑ. Colony PCR and sequencing is then carried out to verify the plasmid construct, of which is extracted and transformed into BL21(DE3) strain for expression. After IPTG induction and overnight incubation, the liquid culture is harvested and, after cell lysis, have an SDS-PAGE run. The results suggest that HxTx-Hv1h had achieved soluble expression. After several unsuccessful purification attempts, the supernatant is treated directly by SUMO protease [Fig2C].
 
<center><html><img src="https://static.igem.wiki/teams/5184/parts/hv1h-sumo.webp" width="600"/></html></center>
 
<center><html><img src="https://static.igem.wiki/teams/5184/parts/hv1h-sumo.webp" width="600"/></html></center>
 
<center><b>Fig2: (A) G1M5 tag allows secretion of the fusion protein into extracellular milieu (B) Plasmid construct pET28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His (C) SDS-PAGE of supernatant and SUMO-treated supernatant, with supernatant of similarly treated supernatant of BL21(DE3) as control</b></center>  
 
<center><b>Fig2: (A) G1M5 tag allows secretion of the fusion protein into extracellular milieu (B) Plasmid construct pET28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His (C) SDS-PAGE of supernatant and SUMO-treated supernatant, with supernatant of similarly treated supernatant of BL21(DE3) as control</b></center>  
Line 28: Line 28:
  
 
==Part Collection==
 
==Part Collection==
−
Our part collection provides a comprehensive list of venom peptides with a diverse range of molecular targets, and all displays satisfactory elimination efficacy during our testings [Fig7A&B].
+
Our part collection provides a comprehensive list of venom peptides with a diverse range of molecular targets, which suppresses the development of drug resistance, and thus ensuring the efficacy of our acaricide. Through the incorporation of a G1M5-SUMO tag, all of the venom peptides are successfully expressed and digested by SUMO protease. According to the toxicity bioassay, all of the venom peptides display significant contact efficacy[Fig8A&B], especially PpVP2S, a novel MVP that we discovered by ourselves through genome mining. In future applications, we hope that our collection of venom peptides will not only be highly effective, but also solve the problem of drug resistance development that traditional pesticides always encounter.
−
<center><html><img src="https://static.igem.wiki/teams/5184/parts/vp-lethality.webp" width="600"/></html></center>
+
<center><html><img src="https://static.igem.wiki/teams/5184/parts/vp-lethality-v.webp" width="600"/></html></center>
−
<center><b>Fig7: A. Survival plot of 6 venom peptides against female ''T. urticae'' using a spraying method, CK is induced liquid culture of BL21(DE3), of which acts as control D. Lethality data of 6 venom peptides over 24, 48, and 72 hours, CK is induced liquid culture of BL21(DE3), of which acts as control; data is the means of ± SD of three parallel replicate experiments</b></center>
+
<center><b>Fig8: A. Survival plot of 6 venom peptides against female ''T. urticae'' using a spraying method, CK is induced liquid culture of BL21(DE3), of which acts as control D. Lethality data of 6 venom peptides over 24, 48, and 72 hours, CK is induced liquid culture of BL21(DE3), of which acts as control; data is the means of ± SD of three parallel replicate experiments</b></center>
  
 
{|class="wikitable" style="margin:auto"
 
{|class="wikitable" style="margin:auto"

Latest revision as of 13:03, 2 October 2024


HxTx-Hv1h

In order to eliminate spider mites, spider venom peptide HxTx-Hv1h is incorporated in our project to broaden the spectrum of molecular targets of venom peptides. HxTx-Hv1h is a small cysteine-rich venom peptide derived from Hadronyche versuta. Utilized as predatory toxin in nature, it carries the ability to cause paralysis and death in susceptible subjects by interfering with voltage-gated calcium and potassium channels. Given CaV and KV channels' roles in neurotransmitter release and neural impulse relay, HxTx-Hv1h serves as an effective pesticide.

Sequences

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Usage and Biology

HxTx-Hv1h is a 39aa long peptide containing 6 cysteine residues arranged to create a cysteine framework of C1xxxC2xxxC3C4xxxC5xxxC6, forming cysteine cross bridges between C1C4, C2C6, and between C3C5 [Fig1A].

Fig1: (A) Cysteine cross-bridge structure in HxTx-Hv1h (B) Secondary structure of HxTx-Hv1h, by structural prediction results from AlphaFold. The cysteine residues are colored orange, displaying their side chains and the rest of the peptide in white

Paralysis and mortal effects of susceptible subjects are achieved via HxTx-Hv1h inhibition on both CaV and KCa channels of susceptible targets by blocking the channels directly, resulting in impediment of fundamental nervous system responses in neuronal, muscular, and cardiac functions. (Specific site of inhibition depends on the concentration of neurotoxin).

Toxicity Verification

HxTx-Hv1h is synthesized using the vector pET28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His[Fig2B], of which is assembled using GoldenGate cloning and transformed into E. coli strain DH5ɑ. Colony PCR and sequencing is then carried out to verify the plasmid construct, of which is extracted and transformed into BL21(DE3) strain for expression. After IPTG induction and overnight incubation, the liquid culture is harvested and, after cell lysis, have an SDS-PAGE run. The results suggest that HxTx-Hv1h had achieved soluble expression. After several unsuccessful purification attempts, the supernatant is treated directly by SUMO protease [Fig2C].

Fig2: (A) G1M5 tag allows secretion of the fusion protein into extracellular milieu (B) Plasmid construct pET28a-G1M5-His-SUMO-HxTx-Hv1h-GNA-His (C) SDS-PAGE of supernatant and SUMO-treated supernatant, with supernatant of similarly treated supernatant of BL21(DE3) as control

The SUMO-digested supernatant's toxicity against T. urticae females is tested using a spraying method by Professor Huang from SCAU. Results from the toxicity assay suggests HxTx-Hv1h to be highly toxic against T. urticae, achieving an fatality of 90.91% within 72 hours.

Fig2: (A) T. urticae in their normal state, before being sprayed with treated supernatant (B) Dead T. urticae from spraying of treated supernatant (C) Survival plot of T. urticae being sprayed with supernatant containing HxTx-Hv1h over 72 hours, CK is similarly processed supernatant of BL21(DE3), acting as a control (D) Lethality data of T. urticae being sprayed with supernatant over 24, 48, and 72 hours, CK is the similarly processed supernatant of BL21(DE3), acting as a control

Part Collection

Our part collection provides a comprehensive list of venom peptides with a diverse range of molecular targets, which suppresses the development of drug resistance, and thus ensuring the efficacy of our acaricide. Through the incorporation of a G1M5-SUMO tag, all of the venom peptides are successfully expressed and digested by SUMO protease. According to the toxicity bioassay, all of the venom peptides display significant contact efficacy[Fig8A&B], especially PpVP2S, a novel MVP that we discovered by ourselves through genome mining. In future applications, we hope that our collection of venom peptides will not only be highly effective, but also solve the problem of drug resistance development that traditional pesticides always encounter.

Fig8: A. Survival plot of 6 venom peptides against female T. urticae using a spraying method, CK is induced liquid culture of BL21(DE3), of which acts as control D. Lethality data of 6 venom peptides over 24, 48, and 72 hours, CK is induced liquid culture of BL21(DE3), of which acts as control; data is the means of ± SD of three parallel replicate experiments
Our Part Collection
Current VP Venom Name Targeted Ion Channel New? Part Number Original Specie
PpVP2S Ca New BBa_K5184043 Phytoseiulus persimilis
PpVP1S Ca New BBa_K5184042 Phytoseiulus persimilis
PpVP1F Ca New BBa_K5184038 Phytoseiulus persimilis
rCtx4 Na BBa_K5184021 Phoneutria depilata
Cs1A Ca BBa_K5184032 Calommata signata
✳️ HxTx-Hv1h Ca, K BBa_K5184033 Hadronyche versuta